| 英文摘要 |
Peripheral blood stem cell transplantation is a stem cell therapy. To collect peripheral blood stem cells, donor needs to inject granulocyte colony stimulating factor, an immunostimulant to mobilize the blood stem cells in bone marrow to peripheral blood several days before and during the harvest day. Because the collection timing is very important, we use automatic hematology analyzer and flow cytometry to analyze the cell numbers of white blood cell (WBC) and hematopoietic stem cell before harvest. The correlation coefficient between hematopoietic stem cell counts and total stem cell counts of final product is higher than the correlation coefficient between WBC counts and total stem cell counts of final product. The correlation between the numbers of WBC detected by the two instruments is higher than the numbers of hematopoietic stem cell, but the two instruments still can be used to evaluate the clinical collection timing. The age of the donor and whether the source is autologous or allogeneic have little effect on the cell counts of product. If we want the total stem cell counts of final product to meet the target goal, the concentration of peripheral blood stem cells after mobilizing should be higher than 19 cells /μl. |